DANA PILZ: Open Payments
NPI 1629264676 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,296 in 54 payments from 16 companies in 2025. Trend: 2023 $765 · 2024 $1,020 · 2025 $1,296
Food & beverage: $1,196Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $223 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $192 |
| Amgen Inc. | 8 | $186 |
| UCB, Inc. | 4 | $130 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Janssen Biotech, Inc. | 4 | $83 |
| Lilly USA, LLC | 3 | $74 |
| GENZYME CORPORATION | 2 | $60 |
| Galderma Laboratories, L.P. | 3 | $53 |
| MERZ NORTH AMERICA, INC. | 2 | $49 |
Products named: OTEZLA, SKYRIZI, Bimzelx, TREMFYA, DUPIXENT, RINVOQ, COSENTYX, Xeomin.
Industry payments across FL — which companies pay providers there.
